MORR F Lipid Solution 5% Intas Pharmaceuticals

£36.00

MORR F Lipid Solution 5% is a finasteride-based investigational compound designed for in-vitro research examining 5α-reductase inhibition pathways and androgenic hormone metabolism studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
MORR F Lipid Solution 5% Intas Pharmaceuticals
MORR F Lipid Solution 5% Intas Pharmaceuticals
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Investigational Overview

MORR F Lipid Solution 5% is a finasteride-based research compound formulated for laboratory analysis of 5α-reductase enzyme inhibition mechanisms. Finasteride belongs to the class of azasteroid compounds that demonstrate competitive inhibition of 5α-reductase type II enzyme activity in experimental models. This lipid solution formulation enables researchers at Stroid UK Shop to examine topical delivery mechanisms and tissue-specific enzyme modulation pathways through controlled in-vitro investigations.

Research Applications in Laboratory Studies

Research teams investigating androgenic hormone metabolism pathways utilise this compound to study 5α-reductase inhibition in tissue culture systems and biochemical assays. The 5% concentration provides standardised dosing for examining enzyme kinetics and substrate competition mechanisms in controlled laboratory environments. Studies examining aromatase inhibitors and finasteride compounds frequently incorporate this formulation to analyse comparative enzyme inhibition profiles and metabolic pathway interactions. The lipid-based delivery system allows researchers to investigate enhanced bioavailability and tissue penetration characteristics compared to conventional formulations.

Technical Specifications and Analysis

MORR F Lipid Solution 5% Research Specifications
Parameter Specification
Active Compound Finasteride 5%
Manufacturer Intas Pharmaceuticals
Formulation Type Lipid Solution
CAS Number 98319-26-7
Molecular Formula C₂₃H₃₆N₂O₂
Storage Requirements Room temperature, protect from light

Laboratory protocols examining selective androgen receptor modulators often incorporate 5α-reductase inhibitor studies to understand androgenic pathway modulation. Comparative research with peptide-based compounds provides insights into alternative approaches for investigating hormonal regulation mechanisms in experimental systems.

Compliance and Research Protocols

This research compound is manufactured by Intas Pharmaceuticals under controlled laboratory conditions for exclusive use in in-vitro research applications. All investigations must adhere to institutional guidelines for chemical handling and disposal procedures. Researchers should verify compound specifications through appropriate analytical methods before experimental use. This product is strictly intended for laboratory research purposes only and is not approved for human consumption, therapeutic use, or any clinical applications.

Related